bioinformatics -

bioinformatics -

www.decode.comdeCode.comwww.celera.comCelera Genomics: Advanced Technologies, Advanced Therapieswww.glycogenesys.comGlycoGenesys, Inc.www.exelixis.comExelixis-an integrated drug discovery and development company,...www.cgen.comAlternative Splicing, Antisense Geneswww.zymogenetics.comZymoGeneticswww.sensoryarts.comSensory Arts & Science - Sensory technology and products...www.ipsogen.comIpsogen - Homewww.integragen.comIntegraGen.comwww.advancedclinical.comAdvanced Clinical Services LLC

deCode.comwww.decode.comHeadquartered in Reykjavik, Iceland, deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery - our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease. The company currently has eight lead programs in drug discovery and development, including three in clinical trials, and is broadening its pipeline through gene and target discovery work in 50 of the most common diseases. deCODE is also leveraging its expertise in human genetics and integrated drug discovery and development capabilities to offer innovative products and services in DNA-based diagnostics, bioinformatics, genotyping, structural biology, drug discovery and clinical development.

Celera Genomics: Advanced Technologies, Advanced Therapieswww.celera.comCelera''s mission is to discover and develop meaningful new therapies that improve human health. We are applying our diverse genomics, bioinformatics, proteomics, medicinal chemistry and biology technology platforms to identify and validate drug targets, a

GlycoGenesys, Inc.www.glycogenesys.comGlycoGenesys, Inc. is a biotechnology company developing novel pharmaceutical products based on carbohydrate compounds. This field is called Glycomics and is the latest step after genomics and proteomics in the development of a complete understanding of the human organism. The company''s lead drug candidate GCS-100, a potential treatment for multiple forms of cancer, recently completed Phase II(a) clinical trials for pancreatic cancer and colorectal cancer.

Exelixis-an integrated drug discovery and development company,...www.exelixis.comExelixis is an integrated drug discovery and development company. Our primary mission is to improve patient care by developing proprietary human therapeutics that target the complex molecular causes of disease.

Alternative Splicing, Antisense Geneswww.cgen.com

ZymoGeneticswww.zymogenetics.comZymoGenetics targets promising protein therapies.

Sensory Arts & Science - Sensory technology and products...www.sensoryarts.comSensory Arts develops sensory technology and products for health and safety.

Ipsogen - Homewww.ipsogen.comCancer Profiler, a solution to personalised Cancer Treatment and rapid development of new cancer drugs. Ipsogen provides oncologists and researchers with a straightforward approach to molecular cancer profiling: molecular diagnostic tools - Associated information systems and prognostic aids - Patented gene expression signatures for each tumour type

IntegraGen.comwww.integragen.comWe deliver validated disease markers and therapeutic targets for a better diagnosis and a causal treatment of common diseases, based on our unique genomic analysis expertise.

Advanced Clinical Services LLCwww.advancedclinical.comAdvanced Clinical Services provides nationwide clinical trials staffing services that unite clinical trial sponsors and CROs with the exceptional professionals in the Pharmaceutical Biotech industry.

Copyright 2004-2006 Tortuga Group LLC, All rights reserved.